Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions

被引：15
|
作者：
Cesinaro, AM
Natoli, C
Grassadonia, A
Tinari, N
Iacobelli, S
Trentini, GP
机构：
[1] Univ Modena & Reggio Emilia, Sect Pathol Anat, Dept Morphol Sci & Legal Med, Modena, Italy
[2] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
10.1046/j.1523-1747.2002.17642.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [41] INTERLEUKIN-2 RECEPTOR EXPRESSION IN BENIGN AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    KERNOHAN, NM
    SEWELL, HF
    JOURNAL OF PATHOLOGY, 1989, 157 (04): : 315 - 319
  • [42] p16ink4a Expression in Benign and Malignant Melanocytic Conjunctival Lesions
    Zoroquiain, Pablo
    Fernandes, Bruno F.
    Gonzalez, Sergio
    Novais, Gustavo N.
    Schalper, Kurt A.
    Burnier, Miguel N., Jr.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2012, 20 (03) : 240 - 245
  • [43] TRANSFORMATION ASSOCIATED REACTIVITY OF MONOCLONAL-ANTIBODIES WITH BENIGN AND MALIGNANT LESIONS OF THE MELANOCYTIC LINEAGE
    KAUDEWITZ, P
    HOLZMANN, B
    JOHNSON, J
    BIEBER, T
    KONZ, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 86 (03) : 334 - 335
  • [44] Protein kinase C alpha expression in benign and malignant melanocytic proliferations.
    Shoji, O
    Bhawan, J
    Byers, HR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 545 - 545
  • [45] Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures
    Curry, Edward W. J.
    Stronach, Euan A.
    Rama, Nona R.
    Wang, Yuepeng Y. P.
    Gabra, Hani
    El-Bahrawy, Mona A.
    MODERN PATHOLOGY, 2014, 27 (03) : 433 - 442
  • [46] Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions
    Kuzbicki, Lukasz
    Gajo, Bernadetta
    Chwirot, Barbara W.
    MELANOMA RESEARCH, 2006, 16 (03) : 235 - 243
  • [47] The histologic diagnosis of primary benign and malignant cutaneous melanocytic lesions
    Sanusi, ID
    JOURNAL OF HISTOTECHNOLOGY, 2003, 26 (04) : 227 - 230
  • [48] AGNORS IN BENIGN, DYSPLASTIC, AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    HOWAT, AJ
    WRIGHT, AL
    COTTON, DWK
    REEVE, S
    BLEEHEN, SS
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (02) : 156 - 161
  • [49] Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy
    Speeckaert, R.
    van Geel, N.
    Vermaelen, K. V.
    Lambert, J.
    Van Gele, M.
    Speeckaert, M. M.
    Brochez, L.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (02) : 334 - 344
  • [50] Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions
    Keijser, S
    Missotten, GS
    Bonfrer, JM
    de Wolff- Rouendaal, D
    Jager, MJ
    de Keizer, RJW
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (02) : 213 - 217
12345